ArticleCytotherapy2016

A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy.

Abdullah Alsuliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.